Company & Sponsor Intelligence
Spanish Foundation for Neurometrics Development
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting0
Completed4
Countries2
Therapeutic footprint
adhdautismepilepsy
Indexed studies
NCT02004236Fronto-temporal tDCS Mproves Fluency & Empathy in ASD Kids
autism · United KingdomNA
autism · United KingdomNA
NCT05825274TDCs to Treat Drug-resistant Epilepsy
epilepsy · United KingdomNA
epilepsy · United KingdomNA
NCT01876524tRNS in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients
adhd · SpainNA
adhd · SpainNA
NCT02614599Neurocognitive and Neurobiological Improvement in ADHD Children With High Protein Diet
adhd · EARLY_PHASE1
adhd · EARLY_PHASE1
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →